RAPT Therapeutics
Why Robinhood?
You can watch RAPT and buy or sell other stocks, ETFs, and their options commission-free!About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
RAPT Key Statistics
Stock Snapshot
As of today, RAPT Therapeutics(RAPT) shares are valued at $10.52. The company's market cap stands at 177.32M, with a P/E ratio of -5.24.
On 2026-06-06, RAPT Therapeutics(RAPT) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.2M.
The stock's 52-week range extends from a low of $5.67 to a high of $58.02.
The stock's 52-week range extends from a low of $5.67 to a high of $58.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.